Artículos por temáticas

A case report of palatal tremor in progressive supranuclear palsy

Cataniag P, Ong JN, Diesta CC.

Parkinsonism Relat Disord. 2025 Jul;136:107324. doi: 10.1016/j.parkreldis.2025.107324. Epub 2025 Feb 13.

Long-term efficacy of deep brain stimulation in PLA2G6-related Parkinson's disease: A case report with literature review

Tsuboi T, Uematsu T, Ito Y, Ishizaki T, Maesawa S, Saito R, Yoshino H, Hattori N, Ramirez-Zamora A, Okun MS, Katsuno M.

Clin Park Relat Disord. 2025 Jul 28;13:100377. doi: 10.1016/j.prdoa.2025.100377. eCollection 2025.

Case Report: Decoding genetic risks of vascular parkinsonism: a case series

Shalash A, El-Shafie S, George P, Roushdy T, Fathy M, Yousef MH, El-Belkimy M, Abdulghani MO, Salama M.

Front Genet. 2025 Jul 25;16:1579454. doi: 10.3389/fgene.2025.1579454. eCollection 2025.

X chromosome-wide association studies in neurological disorders: uncovering the hidden influence of the X chromosome

Step K, Leal TP, Kamel WA, Waldo E, Bardien S, Mata IF.

Front Genet. 2025 Jul 30;16:1650259. doi: 10.3389/fgene.2025.1650259. eCollection 2025.

Relationship of S100 Proteins with Neuroinflammation

García-Domínguez M.

Biomolecules. 2025 Aug 4;15(8):1125. doi: 10.3390/biom15081125.

Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial

Koszycki D, Taljaard M, Bradwejn J, Lee C, Tasca GA, Grimes DA.

Mov Disord. 2025 Aug;40(8):1539-1550. doi: 10.1002/mds.30061. Epub 2024 Nov 20.

Corrigendum to "Flavonoids: Their putative neurological roles, epigenetic changes, and gut microbiota alterations in Parkinson's disease" [Biomed. Pharmacother. 168 (2023) 115788]

Açar Y, Ağagündüz D, De Cicco P, Capasso R.

Biomed Pharmacother. 2025 Aug;189:118231. doi: 10.1016/j.biopha.2025.118231. Epub 2025 Jun 11.

Focal Dystonia in a Patient With Young-Onset Parkinsonism: A Diagnostic Challenge

Longi AA, Shetty P, Fazlani M, Alnims M, Ali N.

Cureus. 2025 Aug 16;17(8):e90203. doi: 10.7759/cureus.90203. eCollection 2025 Aug.

Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders

Li CH, Hsueh SJ, Tsai LK, Chang WH, Cheng SY, Cheng HM, Yeh CF, Lin YH, Tsai HH.

J Formos Med Assoc. 2025 Jul;124 Suppl 1:S55-S62. doi: 10.1016/j.jfma.2025.01.008. Epub 2025 Jan 15.

Trusting Your Gut When it Comes to the Origin of Parkinson's Disease

Borghammer P, Van Den Berge N, Skjærbæk C, Horsager J.

Mov Disord. 2025 Aug;40(8):1735-1737. doi: 10.1002/mds.30288. Epub 2025 Jul 7.

Corrigendum to "Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach" [Brain, Behavior, and Immunity 117 (2024) 270-282]

Liu J, Lv X, Ye T, Zhao M, Chen Z, Zhang Y, Yang W, Xie H, Zhan L, Chen L, Liu WC, Su KP, Sun J.

Brain Behav Immun. 2025 Aug;128:776. doi: 10.1016/j.bbi.2025.06.006. Epub 2025 Jun 17.

Seed Amplification Assay for α-Synuclein: Diagnostic Applications in Synucleinopathies

Giannakis A, Pechlivani L, Sioka C, Alexiou G, Konitsiotis S, Kyritsis AP.

Int J Mol Sci. 2025 Aug 13;26(16):7817. doi: 10.3390/ijms26167817.

A reset on our reclined position-a call to prioritize neurogenic supine hypertension in the synucleinopathies

Miller-Patterson C, Lenka A, Juraschek S, Park J, Beach PA.

Clin Auton Res. 2025 Aug;35(4):545-551. doi: 10.1007/s10286-025-01140-w. Epub 2025 Jun 18.

The interplay between circadian rhythms and aging: molecular mechanisms and therapeutic strategies

Dhaka P, Neha, Kumar R, Hossain CM, Parvez S.

Biogerontology. 2025 Aug 27;26(5):173. doi: 10.1007/s10522-025-10301-3.

Pilot Study of [(11)C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer

Hsieh CJ, Saturnino Guarino D, Young AJ, Siderowf AD, Nasrallah I, Schmitz A, Garcia C, Kim HY, Schubert EK, Lee H, Perlmutter JS, Mach RH.

Cells. 2025 Jul 26;14(15):1157. doi: 10.3390/cells14151157.